Found: 7
Select item for more details and to access through your institution.
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 12809, doi. 10.3390/ijms222312809
- By:
- Publication type:
- Article
Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~.
- Published in:
- Genes & Environment, 2023, v. 45, n. 1, p. 1, doi. 10.1186/s41021-023-00287-0
- By:
- Publication type:
- Article
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 307, doi. 10.1007/s10549-020-05957-z
- By:
- Publication type:
- Article
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 2, p. 478, doi. 10.1007/s12282-020-01185-x
- By:
- Publication type:
- Article
Influences of preoperative metformin on immunological factors in early breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report.
- Published in:
- Surgical Case Reports, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40792-020-0790-7
- By:
- Publication type:
- Article
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2020, v. 20, n. 2, p. 117, doi. 10.1016/j.clbc.2019.07.001
- By:
- Publication type:
- Article